Invention Grant
- Patent Title: Antibody binding to TMEM132A, anticancer agent, and cancer test method
-
Application No.: US16325315Application Date: 2017-08-14
-
Publication No.: US11192956B2Publication Date: 2021-12-07
- Inventor: Yasuhiro Matsumura , Masahiro Yasunaga , Shinji Saijo , Shingo Hanaoka
- Applicant: NATIONAL CANCER CENTER JAPAN , RIN INSTITUTE INC.
- Applicant Address: JP Tokyo; JP Tokyo
- Assignee: NATIONAL CANCER CENTER JAPAN,RIN INSTITUTE INC.
- Current Assignee: NATIONAL CANCER CENTER JAPAN,RIN INSTITUTE INC.
- Current Assignee Address: JP Tokyo; JP Tokyo
- Agency: Clark & Elbing LLP
- Agent Susan M. Michaud
- Priority: JPJP2016-159342 20160815
- International Application: PCT/JP2017/029251 WO 20170814
- International Announcement: WO2018/034259 WO 20180222
- Main IPC: C07K16/30
- IPC: C07K16/30 ; A61P43/00 ; A61K45/00 ; G01N33/53 ; G01N33/574 ; A61P35/00 ; A61K39/395 ; C07K16/28 ; A61K47/68 ; C12N15/09
Abstract:
[Problem]
The present invention provides an antibody that binds to TMEM132A, an anticancer agent and a cancer test method.
[Solution]
An antibody that binds to TMEM132A.
The present invention provides an antibody that binds to TMEM132A, an anticancer agent and a cancer test method.
[Solution]
An antibody that binds to TMEM132A.
Public/Granted literature
- US20190225704A1 ANTIBODY BINDING TO TMEM132A, ANTICANCER AGENT, AND CANCER TEST METHOD Public/Granted day:2019-07-25
Information query
